ZA812735B - Anti-inflammatory compositions - Google Patents

Anti-inflammatory compositions

Info

Publication number
ZA812735B
ZA812735B ZA00812735A ZA812735A ZA812735B ZA 812735 B ZA812735 B ZA 812735B ZA 00812735 A ZA00812735 A ZA 00812735A ZA 812735 A ZA812735 A ZA 812735A ZA 812735 B ZA812735 B ZA 812735B
Authority
ZA
South Africa
Prior art keywords
inflammatory compositions
inflammatory
compositions
Prior art date
Application number
ZA00812735A
Other languages
English (en)
Inventor
A Boris
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA812735B publication Critical patent/ZA812735B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
ZA00812735A 1980-04-25 1981-04-24 Anti-inflammatory compositions ZA812735B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14369980A 1980-04-25 1980-04-25

Publications (1)

Publication Number Publication Date
ZA812735B true ZA812735B (en) 1982-04-28

Family

ID=22505204

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00812735A ZA812735B (en) 1980-04-25 1981-04-24 Anti-inflammatory compositions

Country Status (13)

Country Link
EP (1) EP0039059B1 (fr)
JP (1) JPS56167623A (fr)
AU (1) AU546086B2 (fr)
BE (1) BE888533A (fr)
CA (1) CA1172565A (fr)
DE (2) DE3174873D1 (fr)
DO (1) DOP1981003011A (fr)
IE (1) IE51990B1 (fr)
IL (1) IL62705A (fr)
NZ (1) NZ196898A (fr)
PH (2) PH17739A (fr)
ZA (1) ZA812735B (fr)
ZW (1) ZW9281A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979441A (en) * 1967-02-27 1975-12-09 American Cyanamid Company 11-(piperazinyl) dibenz (b,f) (1,4) oxazepines and analogous thiazepines
NL137032C (fr) * 1967-03-28 Richardson Merrell Spa
CH539044A (de) * 1967-10-06 1973-08-31 Gnii Orch Poluproduktov I Kras Verfahren zur Herstellung quaternärer Ammoniumsalze von 1,3-Bis-(aminomethyl)-imidazolidonen
BE791348A (fr) * 1971-11-16 1973-05-14 Hoffmann La Roche Composes tricycliques
US4034087A (en) * 1973-12-17 1977-07-05 The Regents Of The University Of Michigan Pharmaceutical composition and process of treatment
DE2401446A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen
US4049809A (en) * 1976-11-24 1977-09-20 American Cyanamid Company Solution of a oxazepine for oral or parenteral administration

Also Published As

Publication number Publication date
EP0039059A3 (en) 1982-05-12
EP0039059B1 (fr) 1986-06-25
BE888533A (fr) 1981-10-23
AU6981281A (en) 1981-10-29
DE3116388A1 (de) 1982-06-24
IE51990B1 (en) 1987-05-13
EP0039059A2 (fr) 1981-11-04
PH18482A (en) 1985-07-18
JPS56167623A (en) 1981-12-23
ZW9281A1 (en) 1982-01-28
IL62705A (en) 1986-04-29
NZ196898A (en) 1984-05-31
DE3174873D1 (en) 1986-07-31
PH17739A (en) 1984-11-23
CA1172565A (fr) 1984-08-14
IE810919L (en) 1981-10-25
AU546086B2 (en) 1985-08-15
DOP1981003011A (es) 1987-07-04

Similar Documents

Publication Publication Date Title
DE3373270D1 (en) Topical anti-inflammatory compositions
DE3164692D1 (en) Ultraviolet-transmissible composition
JPS5740518A (en) Self-oxidizable composition
ZA81136B (en) Pharmaceutical compositions
GB8316766D0 (en) Paint-finishing composition
DE3262847D1 (en) Heat-polymerisable compositions
GB2072504B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB8411035D0 (en) Formaldehyde-binding compositions
GB2076285B (en) Dermatological compositions
GB2080681B (en) Oral compositions
JPS573839A (en) Composition
DE3263502D1 (en) Flavour-release compositions
GB2105190B (en) Light-screen compositions
EP0055593A3 (en) Compositions comprising e-prostaglandins
ZA817684B (en) Pharmaceutical compositions
DE3171421D1 (en) Anaerobically-curing compositions
GB2079153B (en) Acetal-acid compositions
GB2067403B (en) Bezodiazepine compositions
GB2074147B (en) Pitch compositions
ZA792562B (en) Anti-inflammatory compositions
JPS5759941A (en) Composition
EP0046036A3 (en) Compositions
ZW9281A1 (en) Anti-inflammatory compositions
DE3171419D1 (en) Anaerobically-curing compositions